/Investor DB

Catalyst Investors — 2019 Investments

3 investments dated 2019 · listed companies and verified rows first · show all

Weavegetweave.comin𝕏NYSE: WEAVSeries B · Oct 2019

Weave is a customer communication and payments platform that connects data, software, and communication tools to surface relevant information at the point of contact.

AI & Machine LearningEnterprise SoftwareFintechFuture of WorkHealthtechSaaSLehi, US

Brandon Rodman(CEO)inJared Rodman(Founder/CCO)inClint Berry(CTO)inMarcus Bertilson(Executive Officer)inBrett White(Chief Executive Officer)inJason Christiansen(Executive Officer)in

Board seatTyler Newton· per SEC Form D

Co-investorsA.Capital VenturesAlbum VCBessemer Venture PartnersBYU Cougar CapitalCrosslink CapitalFrancisco Partners+18 more

Effectualeffectual.comin𝕏Dec 2019✓ verified

Effectual is a cloud consulting and managed services firm that helps commercial enterprises and public sector customers with IT modernization, including data center exits, legacy application modernization, and cloud optimization.

AI & Machine LearningCloud ComputingEnterprise SoftwareHoboken, US

Robb Allen(Founder)inTom Spalding(Founder)in

BoardMatthew Kim(Manager)

Co-investorsSDC Capital Partners

Galvanizegalvanize.comin𝕏Series C · Sep 2019 · $32M

Galvanize provides customized technical education and training programs to help enterprise teams build skills in AI, machine learning, XP and Agile practices, data pipelines, and cloud operations.

AI & Machine LearningEdTechEnterprise SoftwareFuture of WorkDenver, US

Christopher C. Onan(Executive Officer)James Deters(President and Chief Executive Officer)Lawrence Mandes(Managing Director, New Markets)in

BoardDaniel Pianko(Director)Tatiana Goldstein(Director)Jerrold Miller(Director)

Board seatTyler Newton· per SEC Form D

Co-investorsGilmartin Capital LLCSofinnova PartnersTeamworthy VenturesThe Colorado Impact FundVTF CapitalAlly Bridge Group+5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.